Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA

Oncotarget

Volumn 8, Issue 2, 2017, Pages 2037-2043

  van Rensburg, Ilana C ^a   Wagman, Chandre ^a   Stanley, Kim ^a   Beltran, Caroline ^a   Ronacher, Katharina ^a   Walzl, Gerhard ^a   Loxton, Andre G ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

B cells; FasL; IL5R ; Immune response; Immunity; Immunology and Microbiology Section; Regulatory cells; TB treatment

Indexed keywords

MESSENGER RNA; TUBERCULOSTATIC AGENT; BIOLOGICAL MARKER; FAS LIGAND; FASLG PROTEIN, HUMAN; IL5RA PROTEIN, HUMAN; INTERLEUKIN 5 RECEPTOR ALPHA; PHARMACOLOGICAL BIOMARKER;

ANTIBIOTIC THERAPY; APRIL GENE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD19 GENE; CD38 GENE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FASLG GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IL4 GENE; IL5RA GENE; LUNG TUBERCULOSIS; MALE; REAL TIME POLYMERASE CHAIN REACTION; CASE CONTROL STUDY; DRUG EFFECT; DRUG MONITORING; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PILOT STUDY; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; B-LYMPHOCYTES; BIOMARKERS; BIOMARKERS, PHARMACOLOGICAL; CASE-CONTROL STUDIES; DRUG MONITORING; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; PILOT PROJECTS; PROGNOSIS; RNA, MESSENGER; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 85009820218     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12184     Document Type: Article

References (23)

1. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, Galati D, Bocchino M, Matarese A, Salerno A, Sanduzzi A, Franken WPJ, Ottenhoff THM, et al. Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol. 2010; 40: 2211-20
2. Qiu Z, Zhang M, Zhu Y, Zheng F, Lu P, Liu H, Graner MW, Zhou B, Chen X. Multifunctional CD4 T Cell Responses in Patients with Active Tuberculosis. Sci Rep. 2012; 2
3. Lichtner M, Mascia C, Sauzullo I, Mengoni F, Vita S, Marocco R, Belvisi V, Russo G, Vullo V, Mastroianni CM. Multifunctional Analysis of CD4+T-cell Response as immune-based model for Tuberculosis detection. J Immunol Res. 2015
4. De Valliere S, Abate G, Blazevic A, Heuertz RM, Hoft DF. Enhancement of Innate and Cell-Mediated Immunity by Antimycobacterial Antibodies. Infect Immun. 2005; 73: 6711-20
5. Maglione PJ, Xu J, Chan J. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J Immunol. 2007; 178: 7222-34
6. Maglione PJ, Chan J. How B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol. 2009; 39: 676-86
7. Ganapamo F, Dennis VA, Philipp MT. CD19+ cells produce IFN-γ in mice infected with Borrelia burgdorferi. Eur J Immunol. 2001; 31: 3460-8
8. Liu Q, Liu Z, Rozo CT, Hamed HA, Alem F, Urban JF, Gause WC. The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response. J Immunol. 2007; 179: 3821-30
9. Schultze JL, Michalak S, Lowne J, Wong A, Gilleece MH, Gribben JG, Nadler LM. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med. 1999; 189: 1-12
10. Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G. IL-12p70-Dependent Th1 Induction by Human B Cells Requires Combined Activation with CD40 Ligand and CpG DNA. J Immunol. 2004; 172: 954-63
11. Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, Li R, Jouneau L, Boudinot P, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014; 507: 366-70
12. Klinker MW, Reed TJ, Fox DA, Lundy SK. Interleukin-5 Supports the Expansion of Fas Ligand-Expressing Killer B Cells that Induce Antigen-Specific Apoptosis of CD4+ T Cells and Secrete Interleukin-10. Bobé P, editor. PLoS ONE. 2013; 8: e70131
13. Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, Ezine S, Dy M, Zavala F. Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci. 2013; 110: E2199-208
14. Cliff JM, Lee J-S, Constantinou N, Cho J-E, Clark TG, Ronacher K, King EC, Lukey PT, Duncan K, Van Helden PD, Walzl G, Dockrell HM. Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response. J Infect Dis. 2013; 207: 18-29
15. Berry MPR, Graham CM, McNab FW, Xu Z, Bloch SAA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010; 466: 973-7
16. Anderson ST, Kaforou M, Brent AJ, Wright VJ, Banwell CM, Chagaluka G, Crampin AC, Dockrell HM, French N, Hamilton MS, Hibberd ML, Kern F, Langford PR, et al. Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa. N Engl J Med. 2014; 370: 1712-23
17. Van Rensburg IC, Loxton AG. Transcriptomics: the key to biomarker discovery during tuberculosis? Biomark Med. 2015; 9: 483-95
18. Lundy SK. Killer B lymphocytes: the evidence and the potential. Inflamm Res. 2009
19. Mittrücker H-W, Kaufmann SH. Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol. 2000; 67: 457-63
20. Vences-Catalán F, Santos-Argumedo L. CD38 through the life of a murine B lymphocyte. IUBMB Life. 2011; 63: 840-6
21. Donís-Hernández FR, Parkhouse RME, Santos-Argumedo L. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Eur J Immunol. 2001; 31: 1261-7
22. Tsukamoto Y, Nagai Y, Kariyone A, Shibata T, Kaisho T, Akira S, Miyake K, Takatsu K. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production. Mol Immunol. 2009; 46: 1278-88
23. Manjarrez-Orduño N, Moreno-García ME, Fink K, Santos-Argumedo L. CD38 cross-linking enhances TLRinduced B cell proliferation but decreases IgM plasma cell differentiation. Eur J Immunol. 2007; 37: 358-67